Linezolid-induced Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Jamir Pitton Rissardo; P U Shah; K. Piotrowski; Aswathi Sajeendran; Ana Leticia Fornari Caprara; Olga R. Thon; Joshua Santucci

doi:10.1097/wnf.0000000000000674

February 12, 2026

Linezolid-induced Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

View at Publisher

Ask AI

Bookmark

Share

Key Points

Evaluate the occurrence and implications of linezolid-induced posterior reversible encephalopathy syndrome (PRES).
Presented a clinical case of linezolid-induced PRES.
Reviewed existing literature on PRES related to linezolid use.
Analyzed symptoms, complications, and recovery patterns associated with PRES.
Identified potential hemorrhagic complications linked to linezolid use.
Emphasized the significance of early diagnosis of PRES for better outcomes.
Noted instances of delayed recovery from the syndrome.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

Linezolid-induced PRES is rare but clinically significant. Our case highlights potential hemorrhagic complications and delayed recovery, underscoring the need for early recognition and prompt management.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Rissardo et al. (2026) studied this question.

synapsesocial.com/papers/69b25b7196eeacc4fceca2cc https://doi.org/10.1097/wnf.0000000000000674

View at Publisher

Ask AI

Bookmark

Share

Linezolid-induced Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Linezolid-induced Posterior Reversible Encephalopathy Syndrome: A Case Report and Review of the Literature.

Key Points

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading